StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.21+0.08 (+2.56%)

Close on Nov 19, 2026Market cap $28.79MP/E –Yield –

ProMIS Neurosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

ProMIS Neurosciences's free cash flow for the twelve months ending Dec 31, 2022 was -$17.04M. For fiscal 2022 it was -$17.04M.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$17.04M–
FY2021Dec 31, 2021-$9.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-$4.55M–
Q3 FY2022Sep 30, 2022-$4.64M–
Q2 FY2022Jun 30, 2022-$4.48M–
Q1 FY2022Mar 31, 2022-$3.37M–
Q4 FY2021Dec 31, 2021-$4.05M–

More ProMIS Neurosciences figures

See a number that looks wrong?